PAH and Hyperphenylalaninemia: Indeed, a typical clinical feature of BH4 deficiencies is hyperphenylalaninemia because phenylalanine hydroxylase (PAH) is lacking its cofactor to metabolize phenylalanine into tyrosine (Blau and Erlandsen, 2004; Werner et al., 2011; Himmelreich et al., 2021).